The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.
- Published In:
- Cell metabolism, 21(3), 443-54 (2015)
- Authors:
- Lee, Changhan(3), Zeng, Jennifer, Drew, Brian G, Sallam, Tamer, Martin-Montalvo, Alejandro, Wan, Junxiang, Kim, Su-Jeong, Mehta, Hemal, Hevener, Andrea L, de Cabo, Rafael, Cohen, Pinchas
- Database ID:
- RPEP-02703
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02703APA
Lee, Changhan; Zeng, Jennifer; Drew, Brian G; Sallam, Tamer; Martin-Montalvo, Alejandro; Wan, Junxiang; Kim, Su-Jeong; Mehta, Hemal; Hevener, Andrea L; de Cabo, Rafael; Cohen, Pinchas. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.. Cell metabolism, 21(3), 443-54. https://doi.org/10.1016/j.cmet.2015.02.009
MLA
Lee, Changhan, et al. "The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.." Cell metabolism, 2015. https://doi.org/10.1016/j.cmet.2015.02.009
RethinkPeptides
RethinkPeptides Research Database. "The mitochondrial-derived peptide MOTS-c promotes metabolic ..." RPEP-02703. Retrieved from https://rethinkpeptides.com/research/lee-2015-the-mitochondrialderived-peptide-motsc
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.